ØThe study conducted by the Vall d’Hebron Institute of Oncology (VHIO) in conjunction with the GEICAM cooperative group and other American and Canadian researchers has led to a change in the definition of hormone-sensitive breast tumours
news
The Worldwide Innovative Network (WIN) in personalized cancer medicine consortium, of which the Vall d´Hebron Institute of Oncology (VHIO) is…
Li-Kuo Su, Editor-in-Chief of Cancer Cell will join us at the Hotel Alimara, Monday 14 January 2013, 09:00 – 10:15, …
Established in 2010, this year´s International Prize for Breast Cancer Research has been awarded to Aleix Prat at the 8th Advanced International Breast Cancer Course, 15 – 17 November, Padua Italy, by Pier Franco Conte and Gabriel N. Hortobagyi in recognition of his work using gene expression profiling to better classify tumors and thus achieve a better understanding of the disease.
The Worldwide Innovative Network (WIN) in personalized cancer medicine consortium, of which the Vall d´Hebron Institute of Oncology (VHIO) is…
Vall d’Hebron successfully treats pregnant women with breast cancer • In 2006, the Breast Cancer Unit at the Vall d’Hebron…
Results from Vall d´Hebron´s High Risk and Cancer Prevention Unit (UARPC) recently presented at the European Society of Medical Oncology (ESMO) Congress 2012 (Vienna, 28 September – 02 October) show that the high percentage of premalignant lesions detected in different organs in these adolescents and young people not only justifies these programmes but makes them indispensable.
• The team will be coordinating a study that aims to investigate whether the BKM120 drug can be regarded as…
Nature Medicine´s Senior Editor, Victoria Aranda, will come to VHIO Monday 17 September 2012 to deliver the 4th in the…
New Herceptin® delivery method could vastly simplify breast cancer treatment A new method of delivering a commonly used breast cancer…
